Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M K Angelopoulou"'
P1085: EVALUATION OF GONADAL FUNCTION IN YOUNG WOMEN DIAGNOSED WITH HODGKIN AND NON-HODGKIN LYMPHOMA
Autor:
A. N. Georgopoulou, A. Giannakou, T. P. Vassilakopoulos, M. Siakantaris, N. A. Georgopoulos, S. Kalantaridou, E. Lalou, K. Keramaris, E. Loukari, M. Arapaki, I. Konstantinou, A. Machairas, A. Kopsaftopoulou, I. Mammali, I. Vassilopoulos, D. Galopoulos, M. K. Angelopoulou
Publikováno v:
HemaSphere, Vol 6, Pp 975-976 (2022)
Externí odkaz:
https://doaj.org/article/44eb165722294200a5716d10fddbb947
Autor:
A, Velissari, T P, Vassilakopoulos, M K, Angelopoulou, P, Korkolopoulou, G, Bamias, G, Daikos, K, Konstantopoulos, M, Siakantaris
Publikováno v:
Current Research in Translational Medicine. 70:103330
MALT lymphoma is thought to have a genetic component. Genetic studies in the greek population are rare and genetic determinants remain to be established. The current study aimed to seek correlations between genetic polymorphisms and risk of MALT lymp
Autor:
L Papageorgiou, J V Asimakopoulos, V Telonis, A Zannou, P M Arapaki, T Giannikos, E Nikolaou, G Dryllis, I Konstantinou, A Benekou, G Gainarou, P Flevari, E Sinni, P Tsaftaridis, E Plata, T P Vassilakopoulos, M K Angelopoulou, K Konstantopoulos, J Meletis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbee25d0df07986d894a018b7ae72fc8
Autor:
George Z. Rassidakis, Davaris P, M Siakantari, Ch. Kittas, Gerassimos A. Pangalis, E. Patsouris, Haralambos Zorzos, Athina Androulaki, P Korkolopoulou, M K Angelopoulou, Theodoros P. Vassilakopoulos, F Mitropoulos
Publikováno v:
Histopathology. 38:45-53
AIMS In view of the dual role that DNA topoisomerase IIa (TopoIIa) plays as a cell proliferation marker and as a possible indicator of chemosensitivity, we investigated its expression in non-Hodgkin's lymphomas (NHL) in relation to conventional clini
Autor:
Artemts Tsenga, M K Angelopoulou, Ch. Kittas, E. Patsouris, F N Kontopidou, Euphemia Thomas-Tsagli, Gerassimos A. Pangalis, P Korkolopoulou
Publikováno v:
Histopathology. 33:240-247
Aims: To evaluate the independent prognostic value of apoptotic versus proliferative fractions in a series of 92 patients with non-Hodgkin's lymphomas (NHL). Methods and results Apoptotic fractions were quantified by use of the TdT (terminal deoxynuc
Autor:
T P, Vassilakopoulos, G, Nadali, M K, Angelopoulou, M N, Dimopoulou, M P, Siakantaris, F N, Kontopidou, C, Karkantaris, S I, Kokoris, E M, Dimitriadou, C, Calpadaki, A, Sarantopoulos, Z, Galani, S, Sachanas, M C, Kyrtsonis, P, Tsaftaridis, E, Variamis, P, Panayotidis, G, Pizzolo, A H, Sarris, G A, Pangalis
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 10(1)
Serum beta-2 microglobulin (sbeta(2)m) is an established prognostic factor for several lymphoproliferative disorders. Because its significance in Hodgkin's lymphoma (HL) is controversial, we determined sbeta(2)m levels in pretreatment serum samples o
Autor:
K, Lilakos, N A, Viniou, D, Mavrogianni, T P, Vassilakopoulos, M N, Dimopoulou, E, Plata, M K, Angelopoulou, E, Variami, N, Stavrogianni, D, Liapi, I, Xilouri, A, Galanopoulos, M, Ageloudi, P, Panayiotidis, M, Voulgarelis, J, Rombos, J, Meletis, X, Yataganas, G A, Pangalis
Publikováno v:
Anticancer research. 26(2A)
Activating mutations of the FLT3 receptor tyrosine kinase are common in acute promyelocytic leukemia (APL) but have uncertain prognostic significance. Information regarding FLT3 expression levels in APL without FLT3 mutations is lacking.Using RT-PCR,
Autor:
T P, Vassilakopoulos, M K, Angelopoulou, M P, Siakantaris, F N, Kontopidou, M N, Dimopoulou, A, Barbounis, V, Grigorakis, C, Karkantaris, K, Anargyrou, M, Chatziioannou, J, Rombos, V A, Boussiotis, G, Vaiopoulos, C, Kittas, G A, Pangalis
Publikováno v:
European journal of haematology. 67(5-6)
Advanced Hodgkin's lymphoma (HL) is curable by conventional chemotherapy in 60--70% of patients. The pretreatment identification of a sizeable subgroup of patients with sufficiently low failure-free survival (FFS) to be eligible for investigational t
Autor:
M C, Kyrtsonis, M K, Angelopoulou, F N, Kontopidou, M P, Siakantaris, M N, Dimopoulou, F, Mitropoulos, A, Kalovidouris, G A, Vaiopoulos, G A, Pangalis
Publikováno v:
Acta haematologica. 105(2)
Pulmonary involvement in Waldenström's macroglobulinaemia (WM) occurs in 3-5% of cases, but lung involvement without bone marrow infiltration is extremely rare. We report 2 patients who presented with bilateral consolidations on chest X-ray and non-
Autor:
T P, Vassilakopoulos, G, Nadali, M K, Angelopoulou, M P, Siakantaris, M N, Dimopoulou, F N, Kontopidou, G Z, Rassidakis, I A, Doussis-Anagnostopoulou, M, Hatzioannou, G, Vaiopoulos, C, Kittas, A H, Sarris, G, Pizzolo, G A, Pangalis
Publikováno v:
Haematologica. 86(3)
Interleukin-10 (IL-10) is a pleiotropic cytokine which increases bcl-2 levels and protects cells from steroid or doxorubicin-induced apoptosis. Hodgkin and Reed-Sternberg (HRS) cells bear functional IL-10 receptors. Thus serum IL-10 (sIL-10) might in